General

Cancer Research And Biostatistics statisticians traveled to Singapore earlier this month to attend the International Association for the Study of Lung Cancer Staging and Prognostic Factors Committee which was hosted alongside the annual IASLC 2023 World Conference on Lung Cancer. This renowned conference brings together lung cancer clinicians, researchers and scientists from around the world where the […]

Cancer Research And Biostatistics (CRAB) CEO, Antje Hoering, PhD, is in La Jolla, California, this week where she serves as faculty for the American Society of Hematology Clinical Research Training Institute (ASH CRTI). ASH CRTI is a unique training program for early career hematologists. It comprises a week-long workshop aimed at equipping hematologists with foundational

Friends of Cancer Research work on ctDNA focuses on collaboratively establishing evidence to support the use of ctDNA as an early endpoint. Cancer Research And Biostatistics (CRAB) serves as the independent analysis center for this project and as such we are responsible for all the analyses. CRAB is incredibly proud to be part of this

Cancer Research And Biostatistics (CRAB) founder John Crowley, PhD and CRAB CEO, Antje Hoering, PhD, were invited by Taylor & Francis Group to serve as editors for the Fourth Edition of the Handbook of Statistics in Clinical Oncology. For this fourth edition, Megan Othus, PhD, from the Fred Hutch will join the editorial team. Many

Cancer Research And Biostatistics (CRAB) is excited to be a part of the Pragmatica-Lung trial (S2302) which is set to be activated by 2/27/23. The S2302 Pragmatica-Lung trial is a phase 3 follow-up trial to Lung-MAP. S2302 is a new approach to clinical trials with the intent to streamline the existing model of clinical trials